Lanimostim

Drug Profile

Lanimostim

Alternative Names: Macrophage colony-stimulating factor - Chiron; ZX 550

Latest Information Update: 15 Aug 2007

Price : $50

At a glance

  • Originator Chiron Corporation
  • Class Antifungals; Antineoplastics; Growth factors
  • Mechanism of Action Macrophage colony stimulating factor stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Cancer; Mycoses

Most Recent Events

  • 15 Nov 2002 Suspended - Phase-I for Cancer in USA (SC)
  • 15 Nov 2002 Suspended - Phase-I for Cancer in USA (IV)
  • 15 Nov 2002 Suspended - Phase-II for Mycoses in USA (SC)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top